Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;30(7):1380-1389.
doi: 10.3201/eid3007.231723.

Prevalence of and Risk Factors for Post-COVID-19 Condition during Omicron BA.5-Dominant Wave, Japan

Prevalence of and Risk Factors for Post-COVID-19 Condition during Omicron BA.5-Dominant Wave, Japan

Arisa Iba et al. Emerg Infect Dis. 2024 Jul.

Abstract

The increased risk for post-COVID-19 condition after the Omicron-dominant wave remains unclear. This population-based study included 25,911 persons in Japan 20-69 years of age with confirmed SARS-CoV-2 infection enrolled in the established registry system during July-August 2022 and 25,911 age- and sex-matched noninfected controls who used a self-reported questionnaire in January-February 2023. We compared prevalence and age- and sex-adjusted odds ratios of persistent COVID-19 symptoms (lasting ≥2 months). We evaluated factors associated with post-COVID-19 condition by comparing cases with and without post-COVID-19 condition. We analyzed 14,710 (8,392 cases and 6,318 controls) of 18,183 respondents. Post-COVID-19 condition proportion among cases was 11.8%, higher by 6.3% than 5.5% persistent symptoms among controls. Female sex, underlying medical conditions, mild to moderate acute COVID-19, and vaccination were associated with post-COVID-19 condition. Approximately 12% had post-COVID-19 condition during the Omicron-dominant wave, indicating the need for longer follow-up.

Keywords: BA.5; COVID-19; Japan; Omicron; SARS-CoV-2; post–COVID-19 condition; post–acute COVID-19 syndrome; prevalence; respiratory infections; risk factors; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of participant selection in study of prevalence and risk factors for post–COVID-19 condition during Omicron BA.5–dominant wave, Japan. Of 29,276 residents 20–69 years of age identified in the municipal HER-SYS database as infected with COVID-19, we selected a total of 25,911 participants; we extracted the same number of age- and sex-matched noninfected residents from the Basic Residence Registration System to serve as the control group. HER-SYS, Health Center Real-time Information-sharing System on COVID-19.
Figure 2
Figure 2
Prevalence and age- and sex-adjusted odds ratios of persistent symptoms in cases compared with controls in study of prevalence and risk factors for post–COVID-19 conditions during Omicron BA.5–dominant wave, Japan. All cases and controls are included in the multivariable logistic regression analysis to estimate the odds ratio of developing post–COVID-19 condition among cases compared with controls adjusting for age (as a continuous variable) and sex.

References

    1. World Health Organization. WHO COVID-19 dashboard [cited 2023 Aug 29]. https://covid19.who.int
    1. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102–7. 10.1016/S1473-3099(21)00703-9 - DOI - PMC - PubMed
    1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133–46. 10.1038/s41579-022-00846-2 - DOI - PMC - PubMed
    1. Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10:863–76. 10.1016/S2213-2600(22)00126-6 - DOI - PMC - PubMed
    1. Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13:1957. 10.1038/s41467-022-29521-z - DOI - PMC - PubMed

Supplementary concepts